Bessemer Group Inc Emergent Bio Solutions Inc. Transaction History

Bessemer Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 27, 2022	SELL	$33.11 - $55.01 $9,899 - $16,447	-299 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$56.61 - $80.46 $3,962 - $5,632	-70 Reduced 18.97%	299 $19,000
Q1 2021 May 13, 2021	BUY	$86.23 - $125.19 $6,036 - $8,763	70 Added 23.41%	369 $34,000
Q2 2020 Aug 05, 2020	BUY	$54.33 - $89.52 $16,244 - $26,766	299 New	299 $24,000
Q2 2019 Jul 19, 2019	SELL	$39.92 - $53.86 $1,317 - $1,777	-33 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$48.23 - $66.16 $18,182 - $24,942	-377 Reduced 91.95%	33 $2,000
Q4 2018 Feb 12, 2019	BUY	$55.63 - $73.24 $22,808 - $30,028	410 New	410 $24,000

168

36.3M

352K

770K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $485M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.